Bharat Jasani

12.3k total citations
225 papers, 7.9k citations indexed

About

Bharat Jasani is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bharat Jasani has authored 225 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 68 papers in Molecular Biology and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bharat Jasani's work include Trace Elements in Health (32 papers), HER2/EGFR in Cancer Research (32 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). Bharat Jasani is often cited by papers focused on Trace Elements in Health (32 papers), HER2/EGFR in Cancer Research (32 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). Bharat Jasani collaborates with scholars based in United Kingdom, Germany and United States. Bharat Jasani's co-authors include H. Navabi, Malcolm Adams, G R Newman, Anthony Rhodes, John Morgan, E. D. Williams, Kurt Werner Schmid, Aled Clayton, Malcolm D. Mason and Keith D. Miller and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Bharat Jasani

223 papers receiving 7.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bharat Jasani 3.1k 2.6k 1.3k 1.0k 981 225 7.9k
Philip J. Coates 4.5k 1.4× 3.1k 1.2× 1.3k 1.0× 1.2k 1.1× 1.0k 1.1× 205 9.4k
Grietje Molema 4.9k 1.6× 1.3k 0.5× 1.2k 0.9× 764 0.7× 1.6k 1.6× 229 10.3k
Masayuki Yoshida 2.9k 1.0× 1.9k 0.7× 1.7k 1.3× 1.2k 1.2× 1.8k 1.9× 370 9.8k
L. Clifton Stephens 3.5k 1.1× 2.4k 0.9× 917 0.7× 1.7k 1.6× 598 0.6× 192 8.8k
Dennis K. Burns 4.2k 1.4× 1.8k 0.7× 1.4k 1.1× 896 0.9× 712 0.7× 145 11.0k
Eiichi Morii 4.3k 1.4× 2.5k 1.0× 1.4k 1.0× 1.4k 1.3× 2.9k 3.0× 431 10.4k
Wolfgang Tilgen 2.9k 1.0× 3.2k 1.2× 685 0.5× 606 0.6× 1.8k 1.9× 264 8.4k
James H. Resau 5.2k 1.7× 3.1k 1.2× 1.6k 1.2× 1.4k 1.4× 1.2k 1.2× 186 10.7k
Paul J. Higgins 4.0k 1.3× 1.2k 0.4× 1.5k 1.1× 640 0.6× 1.1k 1.1× 226 8.5k
Werner Müller‐Esterl 3.6k 1.2× 1.0k 0.4× 602 0.4× 538 0.5× 2.2k 2.2× 185 10.6k

Countries citing papers authored by Bharat Jasani

Since Specialization
Citations

This map shows the geographic impact of Bharat Jasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bharat Jasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bharat Jasani more than expected).

Fields of papers citing papers by Bharat Jasani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bharat Jasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bharat Jasani. The network helps show where Bharat Jasani may publish in the future.

Co-authorship network of co-authors of Bharat Jasani

This figure shows the co-authorship network connecting the top 25 collaborators of Bharat Jasani. A scholar is included among the top collaborators of Bharat Jasani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bharat Jasani. Bharat Jasani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parry, Suzanne, Abeer M. Shaaban, Bharat Jasani, & Andrew Dodson. (2023). 54P Proficiency testing for HER2-low expression in breast cancer: Results of the UK NEQAS ICC & ISH programme examining technical and interpretive accuracy. ESMO Open. 8(1). 101278–101278. 1 indexed citations
2.
Robert, Marie E., Josef Rüschoff, Bharat Jasani, et al.. (2023). High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma. Modern Pathology. 36(5). 100154–100154. 37 indexed citations
3.
Schöniger, Sandra & Bharat Jasani. (2022). The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology. Animals. 12(19). 2661–2661. 14 indexed citations
4.
Rüschoff, Josef, Michael Friedrich, Iris Nagelmeier, et al.. (2022). Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(5). 685–694. 46 indexed citations
5.
Schöniger, Sandra, et al.. (2019). A Review on Mammary Tumors in Rabbits: Translation of Pathology into Medical Care. Animals. 9(10). 762–762. 14 indexed citations
6.
Stoß, Oliver, Andreas H. Scheel, Iris Nagelmeier, et al.. (2015). Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data. Modern Pathology. 28(12). 1528–1534. 42 indexed citations
7.
Mercer, Tim R., et al.. (2014). Impact of HER2 copy number in IHC2+/FISH-amplified breast cancer on outcome of adjuvant trastuzumab treatment in a large UK cancer network. British Journal of Cancer. 110(8). 2139–2143. 27 indexed citations
8.
Smith, Christopher G., David J. Fisher, Bart Claes, et al.. (2013). Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab. Clinical Cancer Research. 19(15). 4104–4113. 86 indexed citations
9.
Jasani, Bharat, et al.. (2011). Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer network. British Journal of Cancer. 106(1). 32–38. 19 indexed citations
10.
Bartlett, John M.S., Fiona Campbell, Merdol Ibrahim, et al.. (2010). A UK NEQAS ISH Multicenter Ring Study Using the Ventana HER2 Dual-Color ISH Assay. American Journal of Clinical Pathology. 135(1). 157–162. 32 indexed citations
11.
Vázquez‐Carrera, Manuel, Bharat Jasani, Jennifer B. Stott, et al.. (2009). Adenosine A2 receptor signalling mediates chromogranin A secretion from neuroendocrine Tumours. 19. 2 indexed citations
12.
Seymour, Michel, Robert Wilson, Angela Meade, et al.. (2009). ADDITION OF CETUXIMAB TO OXALIPLATIN-BASED COMBINATION CHEMOTHERAPY (CT) IN PATIENTS WITH K-ras WILD-TYPE ADVANCED COLORECTAL CANCER (ACRC): EFFECTS ON OVERALL SURVIVAL. MRC COIN (CR10) TRIAL RESULTS. Annals of Oncology. 20. 15–15. 1 indexed citations
13.
Shousha, Sami, David Peston, B.K. Amo-Takyi, Matthew A. Morgan, & Bharat Jasani. (2009). Evaluation of automated silver‐enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens. Histopathology. 54(2). 248–253. 38 indexed citations
14.
Walker, R A, J. M. S. Bartlett, Mitch Dowsett, et al.. (2008). HER2 testing in the UK: further update to recommendations. Journal of Clinical Pathology. 61(7). 818–824. 98 indexed citations
15.
Bartlett, John M.S., Merdol Ibrahim, Keith Miller, et al.. (2006). External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme. Journal of Clinical Pathology. 60(7). 816–819. 32 indexed citations
16.
Ellis, Ian O., J. M. S. Bartlett, Mitch Dowsett, et al.. (2004). Best Practice No 176. Journal of Clinical Pathology. 57(3). 233–237. 150 indexed citations
17.
Rhodes, Anthony, Bharat Jasani, Élizabeth Anderson, Andrew Dodson, & André Balaton. (2002). Evaluation of HER-2/neu Immunohistochemical Assay Sensitivity and Scoring on Formalin-Fixed and Paraffin-Processed Cell Lines and Breast Tumors. American Journal of Clinical Pathology. 118(3). 408–417. 135 indexed citations
18.
19.
Navabi, H., Bharat Jasani, Malcolm Adams, et al.. (1997). Generation of in Vitro Autologous Human Cytotoxic T-Cell Response to E7 and HER-2/Neu Oncogene Products Using Ex-Vivo Peptide Loaded Dendritic Cells. Advances in experimental medicine and biology. 417. 583–589. 9 indexed citations
20.
Appleton, Mark, Richard Attanoos, & Bharat Jasani. (1996). Thrombomodulin as a marker of vascular and lymphatic tumours. Histopathology. 29(2). 153–157. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip J. Coates Breakdown of academic impact, for papers by Grietje Molema Breakdown of academic impact, for papers by Masayuki Yoshida Breakdown of academic impact, for papers by L. Clifton Stephens Breakdown of academic impact, for papers by Dennis K. Burns Breakdown of academic impact, for papers by Eiichi Morii Breakdown of academic impact, for papers by Wolfgang Tilgen Breakdown of academic impact, for papers by James H. Resau Breakdown of academic impact, for papers by Paul J. Higgins Breakdown of academic impact, for papers by Werner Müller‐Esterl
Rankless by CCL
2026